BioSpace News Archive

Pharm Country

Feinstein Institute researchers discover how to better record vagus nerve signals

Study published in Bioelectronic Medicine, which is now disseminated by BioMed Central, part of Springer Nature.

March 15, 2018
·
3 min read
Policy

The National Federation of the Blind Applauds the Introduction of Legislation Implementing the Marrakesh Treaty

Treaty will Expand Availability of Accessible Books for Blind and Print Disabled Americans.

March 15, 2018
·
1 min read
Business

Aurinia Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights

Aurinia Pharmaceuticals Inc. has released its financial results for the fourth quarter and year ended December 31, 2017.

March 15, 2018
·
6 min read
Business

Encompass Health announces definitive agreement to acquire Camellia Healthcare

Encompass Health Inc. announced it has entered into a definitive agreement to acquire privately owned Camellia Healthcare and affiliated entities.

March 15, 2018
·
2 min read
Less is More When it Comes to the FDA’s Game-Changing Nicotine Reduction Plan

The FDA’s bold nicotine reduction plan has the potential to be a significant and momentous game-changer if implemented properly and quickly.

March 15, 2018
·
2 min read
Deals

Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock

The gross offering proceeds to Vanda from the sale of the shares are expected to be approximately $93.5 million.

March 15, 2018
·
3 min read
FDA

Exelixis Submits U.S. Supplemental New Drug Application for CABOMETYX® (Cabozantinib) for Previously Treated Advanced Hepatocellular Carcinoma

– In the pivotal phase 3 CELESTIAL trial, CABOMETYX provided a statistically significant and clinically meaningful improvement versus placebo in overall survival (OS) –

March 15, 2018
·
12 min read
Business

Intezyne Taps Veteran Banker E. Russell McAllister as President and CEO

Intezyne announced that the company’s Chief Financial Officer, E. Russell McAllister, has been selected as its next President and Chief Executive Officer.

March 15, 2018
·
2 min read
Pharm Country

Stryker Spine Division’s Tritanium® C Anterior Cervical Cage Gains Momentum With Surgeons

Tritanium C Anterior Cervical Cage Implanted By More Than 300 Surgeons Since Late-October Launch

March 15, 2018
·
4 min read
FDA

Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for erdafitinib in the treatment of urothelial cancer.

March 15, 2018
·
2 min read